BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 11739724)

  • 1. Novel function of the cyclin A binding site of E2F in regulating p53-induced apoptosis in response to DNA damage.
    Hsieh JK; Yap D; O'Connor DJ; Fogal V; Fallis L; Chan F; Zhong S; Lu X
    Mol Cell Biol; 2002 Jan; 22(1):78-93. PubMed ID: 11739724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E2F1 induces phosphorylation of p53 that is coincident with p53 accumulation and apoptosis.
    Rogoff HA; Pickering MT; Debatis ME; Jones S; Kowalik TF
    Mol Cell Biol; 2002 Aug; 22(15):5308-18. PubMed ID: 12101227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the E2F-1/p53/Bax pathway by tauroursodeoxycholic acid in amyloid beta-peptide-induced apoptosis of PC12 cells.
    Ramalho RM; Ribeiro PS; Solá S; Castro RE; Steer CJ; Rodrigues CM
    J Neurochem; 2004 Aug; 90(3):567-75. PubMed ID: 15255934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mdm2 inhibition of p53 induces E2F1 transactivation via p21.
    Wunderlich M; Berberich SJ
    Oncogene; 2002 Jun; 21(28):4414-21. PubMed ID: 12080472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction.
    Hsieh JK; Fredersdorf S; Kouzarides T; Martin K; Lu X
    Genes Dev; 1997 Jul; 11(14):1840-52. PubMed ID: 9242491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription factor E2F-1 is upregulated in response to DNA damage in a manner analogous to that of p53.
    Blattner C; Sparks A; Lane D
    Mol Cell Biol; 1999 May; 19(5):3704-13. PubMed ID: 10207094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the transcription factor DP in apoptosis.
    Hitchens MR; Robbins PD
    Apoptosis; 2003 Oct; 8(5):461-8. PubMed ID: 12975577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apaf-1 is a mediator of E2F-1-induced apoptosis.
    Furukawa Y; Nishimura N; Furukawa Y; Satoh M; Endo H; Iwase S; Yamada H; Matsuda M; Kano Y; Nakamura M
    J Biol Chem; 2002 Oct; 277(42):39760-8. PubMed ID: 12149244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling.
    Fusaro G; Dasgupta P; Rastogi S; Joshi B; Chellappan S
    J Biol Chem; 2003 Nov; 278(48):47853-61. PubMed ID: 14500729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-mediated E2F-1 gene transfer inhibits MDM2 expression and efficiently induces apoptosis in MDM2-overexpressing tumor cells.
    Yang HL; Dong YB; Elliott MJ; Liu TJ; Atienza C; Stilwell A; McMasters KM
    Clin Cancer Res; 1999 Aug; 5(8):2242-50. PubMed ID: 10473112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proapoptotic gene SIVA is a direct transcriptional target for the tumor suppressors p53 and E2F1.
    Fortin A; MacLaurin JG; Arbour N; Cregan SP; Kushwaha N; Callaghan SM; Park DS; Albert PR; Slack RS
    J Biol Chem; 2004 Jul; 279(27):28706-14. PubMed ID: 15105421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein.
    Martin K; Trouche D; Hagemeier C; Sørensen TS; La Thangue NB; Kouzarides T
    Nature; 1995 Jun; 375(6533):691-4. PubMed ID: 7791903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo.
    Tolbert D; Lu X; Yin C; Tantama M; Van Dyke T
    Mol Cell Biol; 2002 Jan; 22(1):370-7. PubMed ID: 11739748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2F-1 cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis.
    Nip J; Strom DK; Fee BE; Zambetti G; Cleveland JL; Hiebert SW
    Mol Cell Biol; 1997 Mar; 17(3):1049-56. PubMed ID: 9032231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MdmX represses E2F1 transactivation.
    Wunderlich M; Ghosh M; Weghorst K; Berberich SJ
    Cell Cycle; 2004 Apr; 3(4):472-8. PubMed ID: 14739777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct repression of the Mcl-1 promoter by E2F1.
    Croxton R; Ma Y; Song L; Haura EB; Cress WD
    Oncogene; 2002 Feb; 21(9):1359-69. PubMed ID: 11857079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional interaction between DP-1 and p53.
    Sørensen TS; Girling R; Lee CW; Gannon J; Bandara LR; La Thangue NB
    Mol Cell Biol; 1996 Oct; 16(10):5888-95. PubMed ID: 8816502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of Bcl-2 homology 3 (BH3)-only proteins by E2F1 mediates apoptosis.
    Hershko T; Ginsberg D
    J Biol Chem; 2004 Mar; 279(10):8627-34. PubMed ID: 14684737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neck.
    Frank DK; Liu TJ; Frederick MJ; Clayman GL
    Clin Cancer Res; 1998 Sep; 4(9):2265-72. PubMed ID: 9748148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.